Brief: Cue Biopharma Announces Pricing Of $10 Million Public Offering
19/12/2025 13:31
Dec 19 (Reuters) - Cue Biopharma Inc CUE.O: CUE BIOPHARMA ANNOUNCES PRICING OF $10 MILLION PUBLIC OFFERING CUE BIOPHARMA INC - SHARES AND WARRANTS SOLD AT COMBINED PRICE OF $0.28 Source text: ID:nGNX6LfJbw Further company coverage: CUE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Biopharma
See all newsU.S. STOCKS ON THE MOVE-Insmed, Marvell, Meta
US STOCKS ON THE MOVE-Meta, Marvell Technology, Insmed
U.S. STOCKS ON THE MOVE-Accenture, Arhaus, Alkermes
Cue Biopharma surges after positive results from mid-stage study for CUE-221
Brief: Cue Biopharma Announces Positive Topline Results From Cue-221 Phase 2 Study In Chronic Spontaneous Urticaria